Human gene therapy vectors derived from feline lentiviruses

Veterinary Immunology and Immunopathology

Volumn 123, Issue 1-2, 2008, Pages 23-31

  Barraza, Román A ^a   Poeschla, Eric M ^a  

^a Mayo Clinic   (United States)

Author keywords

Feline immunodeficiency virus; Gene therapy; Innate immunity; Retroviral vectors

Indexed keywords

DNA; LENTIVIRUS VECTOR; VIRUS VECTOR;

CELL TYPE; DNA INTEGRATION; DNA PACKAGING; FELINE IMMUNODEFICIENCY VIRUS; GENE THERAPY; GENE TRANSFER; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PSEUDOTYPING; RESTRICTION MAPPING; REVIEW; VIROLOGY;

ANIMALS; CATS; GENE THERAPY; GENETIC VECTORS; HIV INFECTIONS; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; TRANSCRIPTION, GENETIC; TRANSDUCTION, GENETIC;

FELINE IMMUNODEFICIENCY VIRUS; FELINE LENTIVIRUSES;

EID: 43149113682     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.01.009     Document Type: Review

References (83)

1. Alisky J.M., Hughes S.M., Sauter S.L., Jolly D., Dubensky Jr. T.W., Staber P.D., Chiorini J.A., and Davidson B.L. Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors. Neuroreport 11 (2000) 2669-2673
2. Beer B., Denner J., Brown C.R., Norley S., zur Megede J., Coulibaly C., Plesker R., Holzammer S., Baier M., Hirsch V.M., and Kurth R. Simian immunodeficiency virus of African green monkeys is apathogenic in the newborn natural host. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 18 (1998) 210-220
3. Bieniasz P.D. Restriction factors: a defense against retroviral infection. Trends Microbiol. 11 (2003) 286-291
4. Brooks A.I., Stein C.S., Hughes S.M., Heth J., McCray Jr. P.M., Sauter S.L., Johnston J.C., Cory-Slechta D.A., Federoff H.J., and Davidson B.L. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 6216-6221
5. Broussard S.R., Staprans S.I., White R., Whitehead E.M., Feinberg M.B., and Allan J.S. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75 (2001) 2262-2275
6. Burns J.C., Friedmann T., Driever W., Burrascano M., and Yee J.K. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8033-8037
7. Chakrabarti L.A. The paradox of simian immunodeficiency virus infection in sooty mangabeys: active viral replication without disease progression. Front. Biosci. 9 (2004) 521-539
8. Chakrabarti L.A., Lewin S.R., Zhang L., Gettie A., Luckay A., Martin L.N., Skulsky E., Ho D.D., Cheng-Mayer C., and Marx P.A. Normal T-cell turnover in sooty mangabeys harboring active simian immunodeficiency virus infection. J. Virol. 74 (2000) 1209-1223
9. Ciuffi A., Llano M., Poeschla E., Hoffmann C., Leipzig J., Shinn P., Ecker J.R., and Bushman F. A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med. 11 (2005) 1287-1289
10. Cronin J., Zhang X.Y., and Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5 (2005) 387-398
11. Cullen B.R. Journey to the center of the cell. Cell 105 (2001) 697-700
12. Curran M.A., and Nolan G.P. Nonprimate lentiviral vectors. Curr. Top. Microbiol. Immunol. 261 (2002) 75-105
13. Curran M.A., and Nolan G.P. Recombinant feline immunodeficiency virus vectors. Preparation and use. Methods Mol. Med. 69 (2002) 335-350
14. Curran M.A., Kaiser S.M., Achacoso P.L., and Nolan G.P. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol. Ther. 1 (2000) 31-38
15. Curran M.A., Ochoa M.S., Molano R.D., Pileggi A., Inverardi L., Kenyon N.S., Nolan G.P., Ricordi C., and Fenjves E.S. Efficient transduction of pancreatic islets by feline immunodeficiency virus vectors. Transplantation 74 (2002) 299-306
16. Dardalhon V., Herpers B., Noraz N., Pflumio F., Guetard D., Leveau C., Dubart-Kupperschmitt A., Charneau P., and Taylor N. Lentivirus-mediated gene transfer in primary T cells is enhanced by a central DNA flap. Gene Ther. 8 (2001) 190-198
17. Derksen T.A., Sauter S.L., and Davidson B.L. Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection. J. Gene Med. 4 (2002) 463-469
18. Djalilian H.R., Tsuboi Y., Ozeki M., Tekin M., Djalilian A.R., Obritch W., and Lin J. Feline immunodeficiency virus-mediated gene therapy of middle ear mucosa cells. Auris Nasus Larynx 29 (2002) 183-186
19. Donello J.E., Loeb J.E., and Hope T.J. Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72 (1998) 5085-5092
20. Engelman A., and Craigie R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 66 (1992) 6361-6369
21. Follenzi A., Ailles L.E., Bakovic S., Geuna M., and Naldini L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25 (2000) 217-222
22. Fouchier R.A., and Malim M.H. Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv. Virus Res. 52 (1999) 275-299
23. Hacker C.V., Vink C.A., Wardell T.W., Lee S., Treasure P., Kingsman S.M., Mitrophanous K.A., and Miskin J.E. The integration profile of EIAV-based vectors. Mol. Ther. 14 (2006) 536-545
24. Harper S.Q., Staber P.D., Beck C.R., Fineberg S.K., Stein C., Ochoa D., and Davidson B.L. Optimization of feline immunodeficiency virus vectors for RNA interference. J. Virol. 80 (2006) 9371-9380
25. Haskell R.E., Hughes S.M., Chiorini J.A., Alisky J.M., and Davidson B.L. Viral-mediated delivery of the late-infantile neuronal ceroid lipofuscinosis gene, TPP-I to the mouse central nervous system. Gene Ther. 10 (2003) 34-42
26. Hughes S.M., Moussavi-Harami F., Sauter S.L., and Davidson B.L. Viral-mediated gene transfer to mouse primary neural progenitor cells. Mol. Ther. 5 (2002) 16-24
27. Johnston J.C., Gasmi M., Lim L.E., Elder J.H., Yee J.K., Jolly D.J., Campbell K.P., Davidson B.L., and Sauter S.L. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73 (1999) 4991-5000
28. Kang Y., Stein C.S., Heth J.A., Sinn P.L., Penisten A.K., Staber P.D., Ratliff K.L., Shen H., Barker C.K., Martins I., Sharkey C.M., Sanders D.A., McCray Jr. P.B., and Davidson B.L. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J. Virol. 76 (2002) 9378-9388
29. Kang Y., Xie L., Tran D.T., Stein C.S., Hickey M., Davidson B.L., and McCray Jr. P.B. Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer. Blood 106 (2005) 1552-1558
30. Kang Y., Moressi C.J., Scheetz T.E., Xie L., Tran D.T., Casavant T.L., Ak P., Benham C.J., Davidson B.L., and McCray Jr. P.B. Integration site choice of a feline immunodeficiency virus vector. J. Virol. 80 (2006) 8820-8823
31. Kemler I., Barraza R., and Poeschla E.M. Mapping of the encapsidation determinants of feline immunodeficiency virus. J. Virol. 76 (2002) 11889-11903
32. Kemler I., Azmi I., and Poeschla E.M. The critical role of proximal gag sequences in feline immunodeficiency virus genome encapsidation. Virology 327 (2004) 111-120
33. Khare P., Loewen N., Teo W., Barraza R.A., Saenz D.T., Johnson D.H., and Poeschla E.M. Durable, safe, multi-gene lentiviral vector expression in feline trabecular meshwork. Molecular Therapy 16 1 (2007) 97-106
34. Leavitt A.D., Shiue L., and Varmus H.E. Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro. J. Biol. Chem. 268 (1993) 2113-2119
35. Llano M., Saenz D.T., Meehan A., Wongthida P., Peretz M., Walker W.H., Teo W., and Poeschla E.M. An essential role for LEDGF/p75 in HIV integration. Science 314 (2006) 461-464
36. Loewen N., and Poeschla E.M. Lentiviral vectors. Adv. Biochem. Eng. Biotechnol. 99 (2005) 169-191
37. Loewen N., Fautsch M., Peretz M., Bahler C., Cameron J.D., Johnson D.H., and Poeschla E.M. Genetic modification of human trabecular meshwork with lentiviral vectors. Hum. Gene Ther. 12 (2001) 2109-2119
38. Loewen N., Bahler C., Teo W., Whitwam T., Peretz M., Xu R., Fautsch M., Johnson D.H., and Poeschla E.M. Preservation of aqueous outflow facility after second-generation FIV vector-mediated expression of marker genes in anterior segments of human eyes. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3686-3690
39. Loewen N., Barraza R., Whitwam T., Saenz D.T., Kemler I., and Poeschla E. FIV vectors. Methods Mol. Biol. 229 (2003) 251-271
40. Loewen N., Leske D., Chen Y., Teo W., Saenz D.T., Peretz M., Holmes J., and Poeschla E.M. Comparison of wild-type and class I integrase mutant-FIV vectors in retina demonstrates sustained expression of integrated transgenes in retinal pigment epithelium. J. Gene Med. 5 (2003) 1009-1017
41. Loewen N., Leske D.A., Cameron J.D., Chen Y., Whitwam T., Simari R.D., Teo W.L., Fautsch M.P., Poeschla E.M., and Holmes J.M. Long-term retinal transgene expression with FIV versus adenoviral vectors. Mol. Vis. 10 (2004) 272-280
42. Lotery A.J., Derksen T.A., Russell S.R., Mullins R.F., Sauter S., Affatigato L.M., Stone E.M., and Davidson B.L. Gene transfer to the nonhuman primate retina with recombinant feline immunodeficiency virus vectors. Hum. Gene Ther. 13 (2002) 689-696
43. Mitrophanous K., Yoon S., Rohll J., Patil D., Wilkes F., Kim V., Kingsman S., Kingsman A., and Mazarakis N. Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6 (1999) 1808-1818
44. Naldini L., Bloemer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., and Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272 (1996) 263-267
45. Naldini L., Blomer U., Gage F.H., Trono D., and Verma I.M. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 11382-11388
46. Olsen J.C. Gene transfer vectors derived from equine infectious anemia virus. Gene Ther. 5 (1998) 1481-1487
47. Parolin C., and Sodroski J. A defective HIV-1 vector for gene transfer to human lymphocytes. J. Mol. Med. 73 (1995) 279-288
48. Parolin C., Taddeo B., Palu G., and Sodroski J. Use of cis- and trans-acting viral regulatory sequences to improve expression of human immunodeficiency virus vectors in human lymphocytes. Virology 222 (1996) 415-422
49. Pedersen N.C. The feline immunodeficiency virus. In: Levy J.A. (Ed). The Retroviridae (1993), Plenum Press, New York 181-228
50. Pedersen N.C., Ho E.W., Brown M.L., and Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235 (1987) 790-793
51. Phillips T.R., Lamont C., Konings D.A., Shacklett B.L., Hamson C.A., Luciw P.A., and Elder J.H. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus. J. Virol. 66 (1992) 5464-5471
52. Poeschla E.M. Non-primate lentiviral vectors. Curr. Opin. Mol. Ther. 5 (2003) 529-540
53. Poeschla E., and Looney D. CXCR4 is required by a non-primate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent and feline cells. J. Virol. 72 (1998) 6858-6866
54. Poeschla E., Wong-Staal F., and Looney D. Efficient transduction of nondividing cells by feline immunodeficiency virus lentiviral vectors. Nat. Med. 4 (1998) 354-357
55. Price M.A., Case S.S., Carbonaro D.A., Yu X.J., Petersen D., Sabo K.M., Curran M.A., Engel B.C., Margarian H., Abkowitz J.L., Nolan G.P., Kohn D.B., and Crooks G.M. Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells. Mol. Ther. 6 (2002) 645-652
56. Roelke M.E., Pecon-Slattery J., Taylor S., Citino S., Brown E., Packer C., Vandewoude S., and O'Brien S.J. T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion. J. Wildl. Dis. 42 (2006) 234-248
57. Saenz D.T., and Poeschla E.M. FIV: from lentivirus to lentivector. J. Gene Med. 6 Suppl 1 (2004) S95-S104
58. Saenz D.T., Loewen N., Peretz M., Whitwam T., Barraza R., Howell K., Holmes J.H., Good M., and Poeschla E.M. Unintegrated lentiviral DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants. J. Virol. 78 (2004) 2906-2920
59. Saenz D.T., Teo W., Olsen J.C., and Poeschla E. Restriction of feline immunodeficiency virus by Ref1, LV1 and primate TRIM5a proteins. J. Virol. 79 (2005) 15175-15188
60. Saenz D.T., Barraza R., Loewen N., Teo W., and Poeschla E. Production and use of feline immunodeficiency virus (FIV)-based lentiviral vectors. In: Rossi J., and Friedman T. (Eds). Gene Transfer: A Cold Spring Harbor Laboratory Manual (2006), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York 57-74
61. Schroder A.R., Shinn P., Chen H., Berry C., Ecker J.R., and Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110 (2002) 521-529
62. Shimojima M., Miyazawa T., Ikeda Y., McMonagle E.L., Haining H., Akashi H., Takeuchi Y., Hosie M.J., and Willett B.J. Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science 303 (2004) 1192-1195
63. Shun M.C., Raghavendra N.K., Vandegraaff N., Daigle J.E., Hughes S., Kellam P., Cherepanov P., and Engelman A. LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev. 21 (2007) 1767-1778
64. Sinn P.L., Hickey M.A., Staber P.D., Dylla D.E., Jeffers S.A., Davidson B.L., Sanders D.A., and McCray Jr. P.B. Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J. Virol. 77 (2003) 5902-5910
65. Sirven A., Pflumio F., Zennou V., Titeux M., Vainchenker W., Coulombel L., Dubart-Kupperschmitt A., and Charneau P. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96 (2000) 4103-4110
66. Song J.J., Lee B., Chang J.W., Kim J.H., Kwon Y.K., and Lee H. Optimization of vesicular stomatitis virus-G pseudotyped feline immunodeficiency virus vector for minimized cytotoxicity with efficient gene transfer. Virus Res. 93 (2003) 25-30
67. Stein C.S., and Davidson B.L. Gene transfer to the brain using feline immunodeficiency virus-based lentivirus vectors. Methods Enzymol. 346 (2002) 433-454
68. Stein C.S., Kang Y., Sauter S.L., Townsend K., Staber P., Derksen T.A., Martins I., Qian J., Davidson B.L., and McCray Jr. P.B. In vivo treatment of hemophilia A and mucopolysaccharidosis type VII using nonprimate lentiviral vectors. Mol. Ther. 3 (2001) 850-856
69. Stevenson M. HIV nuclear import: what's the flap?. Nat. Med. 6 (2000) 626-628
70. Stremlau M., Owens C.M., Perron M.J., Kiessling M., Autissier P., and Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 427 (2004) 848-853
71. Talbott R.L., Sparger E.E., Lovelace K.M., Fitch W.M., Pedersen N.C., Luciw P.A., and Elder J.H. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5743-5747
72. Troyer J.L., Pecon-Slattery J., Roelke M.E., Johnson W., VandeWoude S., Vazquez-Salat N., Brown M., Frank L., Woodroffe R., Winterbach C., Winterbach H., Hemson G., Bush M., Alexander K.A., Revilla E., and O'Brien S.J. Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J. Virol. 79 (2005) 8282-8294
73. Van Maele B., De Rijck J., De Clercq E., and Debyser Z. Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction. J. Virol. 77 (2003) 4685-4694
74. Vandekerckhove L., Christ F., Van Maele B., De Rijck J., Gijsbers R., Van den Haute C., Witvrouw M., and Debyser Z. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J. Virol. 80 (2006) 1886-1896
75. Vodicka M.A. Determinants for lentiviral infection of non-dividing cells. Somat. Cell Mol. Genet. 26 (2001) 35-49
76. Wang G., Slepushkin V., Zabner J., Keshavjee S., Johnston J.C., Sauter S.L., Jolly D.J., Dubensky Jr. T.W., Davidson B.L., and McCray Jr. P.B. Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J. Clin. Invest. 104 (1999) R55-R62 (see comments)
77. Whitwam T., Peretz M., and Poeschla E.M. Identification of a central DNA flap in feline immunodeficiency virus. J. Virol. 75 (2001) 9407-9414
78. Willett B.J., Hosie M.J., Neil J.C., Turner J.D., and Hoxie J.A. Common mechanism of infection by lentiviruses. Nature 385 (1997) 587 (letter)
79. Willett B.J., Picard L., Hosie M.J., Turner J.D., Adema K., and Clapham P.R. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71 (1997) 6407-6415
80. Yanez-Munoz R.J., Balaggan K.S., MacNeil A., Howe S.J., Schmidt M., Smith A.J., Buch P., MacLaren R.E., Anderson P.N., Barker S.E., Duran Y., Bartholomae C., von Kalle C., Heckenlively J.R., Kinnon C., Ali R.R., and Thrasher A.J. Effective gene therapy with nonintegrating lentiviral vectors. Nat. Med. 12 (2006) 348-353
81. Yee J.K., Miyanohara A., LaPorte P., Bouic K., Burns J.C., and Friedmann T. A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9564-9568
82. Yu S.F., von Ruden T., Kantoff P.W., Garber C., Seiberg M., Ruther U., Anderson W.F., Wagner E.F., and Gilboa E. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 3194-3198
83. Zennou V., Petit C., Guetard D., Nerhbass U., Montagnier L., and Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101 (2000) 173-185